SCHEMBL2970932

SCHEMBL2970932

NC(=O)c1c([N+](=O)[O-])ccc(N(CCBr)CCBr)c1[N+](=O)[O-]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 4/20 0.39
L3MBTL1 Q9Y468 4/20 0.38
TDP1 Q9NUW8 2/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
NSD2 O96028 1/20 0.36
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
ALDH3A1 P30838 1/20 0.34
MAPT P10636 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPK1 P28482 1/20 0.33
PARP1 P09874 1/20 0.33
TSHR P16473 1/20 0.31
GAA P10253 1/20 0.31
PKM P14618 1/20 0.31
CYP3A4 P08684 1/20 0.31
BLM P54132 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8635371 0.86 HCAR3 (0.39) HCAR3L3MBTL1TDP1KDM4EPOLB
SCHEMBL2977058 0.80 GSTP1 (0.39) HCAR3L3MBTL1TDP1KDM4ENSD2
SCHEMBL14278540 0.79 NSD2 (0.41) HCAR3TDP1KDM4EPOLBNSD2
SCHEMBL2968993 0.78 PRMT5 (0.39) HCAR3TDP1KDM4EPOLBNSD2
SCHEMBL2968995 0.78 PRMT5 (0.38) HCAR3TDP1POLBNSD2NCOA1
SCHEMBL13202989 0.77 TDP1 (0.41) HCAR3L3MBTL1TDP1NSD2NCOA1
SCHEMBL2974168 0.75 KDM4E (0.35) HCAR3L3MBTL1TDP1KDM4EPOLB
SCHEMBL3582399 0.74 ALDH1A1 (0.38) HCAR3L3MBTL1POLBSMN1; SMN2ALDH1A1
SCHEMBL8636703 0.72 MAPT (0.50) HCAR3KDM4EPOLBALDH3A1MAPT
SCHEMBL2975480 0.71 NSD2 (0.44) HCAR3L3MBTL1TDP1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776924-B2 Nitroaniline-based alkylating agents and their use as prodrugs AUCKLAND UNISERVICES LIMITED (NZ) 2010-08-17 US disclosed
US-20050256191-A1 Nitroaniline-based alkylating agents and their use as prodrugs AUCKLAND UNISERVICES LIMITED (NZ) 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256191-A1 Nitroaniline-based alkylating agents and their use as prodrugs IDH3A, HIF1AN, IDH1 HCAR3 689/4885L3MBTL1 1618/4885TDP1 1345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.